Fusen Pharmaceutical Company Limited (1652.HK)

HKD 0.81

(-2.41%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.34 Billion 1.35 Billion 1.23 Billion 1.24 Billion 1.17 Billion 1.16 Billion
Total Current Assets 566.8 Million 614.05 Million 509.22 Million 660.36 Million 674.39 Million 883.76 Million
Cash And Short Term Investments 34.84 Million 128.1 Million 81.7 Million 312.52 Million 331.04 Million 561.1 Million
Cash and Cash Equivalents 34.84 Million 128.1 Million 81.06 Million 297.03 Million 331.04 Million 561.1 Million
Short Term Investments - 4.59 Million 642 Thousand 15.48 Million -19.82 Million -
Net Receivables 183.48 Million 247.18 Million 157.58 Million 183.93 Million 170.16 Million 120.34 Million
Inventory 161.71 Million 110.64 Million 121.84 Million 105.41 Million 88.4 Million 140.78 Million
Other Current Assets 186.75 Million 110.67 Million 140.96 Million 71.89 Million 80.13 Million 181.87 Million
Total Non-Current Assets 776.94 Million 736.21 Million 730.11 Million 580.98 Million 501.83 Million 279.49 Million
Net PPE 352 Million 314.37 Million 285.46 Million 238 Million 124.67 Million 154.44 Million
Good Will And Intangible Assets 255.55 Million 215.85 Million 221.25 Million 248.8 Million 277.7 Million 117.9 Million
Good Will - - - - 7.05 Million -
Intangible Assets 255.55 Million 215.85 Million 221.25 Million 248.8 Million 270.64 Million 117.9 Million
Long-Term Investments 148.97 Million 173.71 Million 197.42 Million 52.15 Million 91.92 Million -
Tax Assets 5.02 Million 5.07 Million 5.62 Million 5.7 Million 5.4 Million 4.84 Million
Other Non Current Assets 15.38 Million 27.19 Million 20.34 Million 36.3 Million 2.12 Million 2.3 Million
Other Assets - - - - - -
Total Liabilities 781.51 Million 737.37 Million 582.39 Million 583.09 Million 494.68 Million 547.16 Million
Total Current Liabilities 664.52 Million 722.08 Million 489.26 Million 547.6 Million 460.8 Million 450.99 Million
Account Payables 167.54 Million 163.61 Million 102.11 Million 108.58 Million 68.89 Million 137.99 Million
Tax Payables 22.34 Million 31.82 Million 28.83 Million 35.56 Million 40.77 Million 62.22 Million
Short Term Debt 237.64 Million 227.94 Million 162.74 Million 178.5 Million 190 Million 100 Million
Deferred Revenue -1.08 Million - - - - -
Other Current Liabilities 260.41 Million 330.52 Million 224.4 Million 260.52 Million 201.9 Million 213 Million
Total Non Current Liabilities 116.99 Million 15.29 Million 93.12 Million 35.49 Million 33.88 Million 96.16 Million
Long-Term Debt 106.47 Million 432 Thousand 77.94 Million 20 Million 20 Million 90 Million
Deferred Revenue Non Current 10.23 Million 11.32 Million 10.5 Million 8.35 Million 6.75 Million 4.47 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - - - -
Other Liabilities - - - - - -
Total Equity 562.22 Million 612.89 Million 656.94 Million 658.24 Million 681.54 Million 616.09 Million
Stock Holders Equity 563.51 Million 614.16 Million 658.16 Million 659.44 Million 673.44 Million 613.93 Million
Common Stock 6.31 Million 6.38 Million 6.47 Million 6.51 Million 6.73 Million 6.73 Million
Retained Earnings 238.53 Million 274.81 Million 309.41 Million 346.84 Million 276.71 Million 223.27 Million
Accumulated other comprehensive income 557.2 Million 32.21 Million 28.78 Million 31.33 Million 14.05 Million -116.06 Million
Common Stock Equity 563.51 Million 614.16 Million 658.16 Million 659.44 Million 673.44 Million 613.93 Million
Capital Lease Obligation 1.85 Million 2.53 Million 3.77 Million - - -
Total Investments 148.97 Million 178.3 Million 198.06 Million 67.64 Million 72.1 Million -
Total Debt 344.11 Million 228.38 Million 240.68 Million 198.5 Million 210 Million 190 Million
Net Debt 309.26 Million 100.27 Million 159.62 Million -98.53 Million -121.04 Million -371.1 Million

Balance Sheet Charts